PDP

MEDİTERA TIBBİ MALZEME SANAYİ VE TİCARET A.Ş.

MEDTR

1.1. Facilitating the Exercise of Shareholders Rights
The number of investor meetings (conference, seminar/etc.) organised by the company during the year	Following the announcement of the 2024 year-end results, the company held an online meeting in 2025 with the participation of our senior management, portfolio management companies, and brokerage firm analysts, and a presentation was made on the financial results.

1.2. Right to Obtain and Examine Information
The number of special audit request(s)	No special auditor was requested.
The number of special audit requests that were accepted at the General Shareholders' Meeting	No special auditor was requested at the general assembly.

1.3. General Assembly
Link to the PDP announcement that demonstrates the information requested by Principle 1.3.1. (a-d)	https://www.kap.org.tr/en/Bildirim/1284135
Whether the company provides materials for the General Shareholders' Meeting in English and Turkish at the same time	Will not be presented.
The links to the PDP announcements associated with the transactions that are not approved by the majority of independent directors or by unanimous votes of present board members in the context of Principle 1.3.9	No announcement has been made as there is no transaction under Principle 1.3.9.
The links to the PDP announcements associated with related party transactions in the context of Article 9 of the Communique on Corporate Governance (II-17.1)	No announcement has been made as no transaction has taken place under the relevant article.
The links to the PDP announcements associated with common and continuous transactions in the context of Article 10 of the Communique on Corporate Governance (II-17.1)	https://www.kap.org.tr/en/Bildirim/1404058
The name of the section on the corporate website that demonstrates the donation policy of the company	Investor Relations>Policies>Donation and Assistance Policy
The relevant link to the PDP with minute of the General Shareholders' Meeting where the donation policy has been approved	https://www.kap.org.tr/en/Bildirim/1417113
The number of the provisions of the articles of association that discuss the participation of stakeholders to the General Shareholders' Meeting	Pursuant to Article 12/a of the Articles of Association, the general meeting shall be held publicly, including stakeholders and the media, without the right to speak.
Identified stakeholder groups that participated in the General Shareholders' Meeting, if any	Shareholders listed in the shareholder list obtained from the Central Securities Depository (CSD) who applied to the Company, members of the Board of Directors, the representative of the Independent Audit Firm, and the Investor Relations Department responsible for preparing the Company's General Assembly attended the General Assembly meeting. However, other stakeholders chose not to attend.

1.4. Voting Rights
Whether the shares of the company have differential voting rights	Evet (Yes)
In case that there are voting privileges, indicate the owner and percentage of the voting majority of shares.	Pursuant to Article 12/ç of the Articles of Association, Group (A) shareholders or their proxies present at the ordinary and extraordinary general assembly meetings have 5 (five) voting rights for each share, and Group (B) shareholders or their proxies have 1 (one) voting right for each share.
The percentage of ownership of the largest shareholder	%56,38

1.5. Minority Rights
Whether the scope of minority rights enlarged (in terms of content or the ratio) in the articles of the association	Hayır (No)
If yes, specify the relevant provision of the articles of association.	-

1.6. Dividend Right
The name of the section on the corporate website that describes the dividend distribution policy	Investor Relations>Policies>Dividend Distribution Policy
Minutes of the relevant agenda item in case the board of directors proposed to the general assembly not to distribute dividends, the reason for such proposal and information as to use of the dividend.	At the 2024 Ordinary General Assembly Meeting, Dividend Distribution Decision was taken.
PDP link to the related general shareholder meeting minutesin case the board of directors proposed to the general assembly not to distribute dividends	-

General Assembly Meetings

General Meeting Date	The number of information requests received by the company regarding the clarification of the agenda of the General Shareholders' Meeting	Shareholder participation rate to the General Shareholders' Meeting	Percentage of shares directly present at the GSM	Percentage of shares represented by proxy	Specify the name of the page of the corporate website that contains the General Shareholders' Meeting minutes, and also indicates for each resolution the voting levels for or against	Specify the name of the page of the corporate website that contains all questions asked in the general assembly meeting and all responses to them	The number of the relevant item or paragraph of General Shareholders' Meeting minutes in relation to related party transactions	The number of declarations by insiders received by the board of directors	The link to the related PDP general shareholder meeting notification
03/04/2025	0	%89,89	%23,06	%66,83	Investor Relations>General Assembly>2024	Investor Relations>General Assembly>2024	-	21	https://www.kap.org.tr/en/Bildirim/1417113

2.1. Corporate Website
Specify the name of the sections of the website providing the information requested by the Principle 2.1.1.	Investor Relations
If applicable, specify the name of the sections of the website providing the list of shareholders (ultimate beneficiaries) who directly or indirectly own more than 5% of the shares.	Investor Relations/Partnership Structure
List of languages for which the website is available	Turkish-English-Spanish

2.2. Annual Report
The page numbers and/or name of the sections in the Annual Report that demonstrate the information requested by principle 2.2.2.
a) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on the duties of the members of the board of directors and executives conducted out of the company and declarations on independence of board members	The duties carried out by the members of the Board of Directors and the executives outside the Company are included in the article ?Other duties carried out by the members of the Board of Directors? under the title of the Board of Directors in the Annual Report of the Board of Directors for the year 2025.
b) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on committees formed within the board structure	Information on the committees established within the Board of Directors is provided in the Annual Report of the Board of Directors for 2025 under the Corporate Governance heading in the article 3.3. Number, Structure and Independence of the Committees Established within the Board of Directors.
c) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on the number of board meetings in a year and the attendance of the members to these meetings	The Board of Directors held 31 meetings with 87% attendance during the period and it is stated in the Corporate Governance section of the Annual Report of the Board of Directors for 2025 under the heading 3.2.
ç) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on amendments in the legislation which may significantly affect the activities of the corporation	2025 is included in the Annual Report of the Board of Directors under the heading Important Developments Regarding Activities.
d) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on significant lawsuits filed against the corporation and the possible results thereof	2025 is included in the Annual Report of the Board of Directors under the heading Important Developments Regarding Activities.
e) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on the conflicts of interest of the corporation among the institutions that it purchases services on matters such as investment consulting and rating and the measures taken by the corporation in order to avoid from these conflicts of interest	Investment advisory and rating services are not provided.
f) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on the cross ownership subsidiaries that the direct contribution to the capital exceeds 5%	There is no cross shareholding where the direct participation rate exceeds 5%.
g) The page numbers and/or name of the sections in the Annual Report that demonstrate the information on social rights and professional training of the employees and activities of corporate social responsibility in respect of the corporate activities that arises social and environmental results	2025 Annual Report of the Board of Directors under the heading of Social Responsibility Projects.

3.1. Corporation's Policy on Stakeholders
The name of the section on the corporate website that demonstrates the employee remedy or severance policy	None.
The number of definitive convictions the company was subject to in relation to breach of employee rights	None.
The position of the person responsible for the alert mechanism (i.e. whistleblowing mechanism)	None.
The contact detail of the company alert mechanism	None.

3.2. Supporting the Participation of the Stakeholders in the Corporation's Management
Name of the section on the corporate website that demonstrates the internal regulation addressing the participation of employees on management bodies	None.
Corporate bodies where employees are actually represented	None.

3.3. Human Resources Policy
The role of the board on developing and ensuring that the company has a succession plan for the key management positions	None.
The name of the section on the corporate website that demonstrates the human resource policy covering equal opportunities and hiring principles. Also provide a summary of relevant parts of the human resource policy.	None.
Whether the company provides an employee stock ownership programme	Pay edindirme planı bulunmuyor (There isn't an employee stock ownership programme)
The name of the section on the corporate website that demonstrates the human resource policy covering discrimination and mistreatments and the measures to prevent them. Also provide a summary of relevant parts of the human resource policy.	None.
The number of definitive convictions the company is subject to in relation to health and safety measures	None.

3.5. Ethical Rules and Social Responsibility
The name of the section on the corporate website that demonstrates the code of ethics	https://www.meditera.com.tr/i/policies
The name of the section on the company website that demonstrates the corporate social responsibility report. If such a report does not exist, provide the information about any measures taken on environmental, social and corporate governance issues.	https://www.meditera.com.tr/i/surdurulebilirlik
Any measures combating any kind of corruption including embezzlement and bribery	All necessary obligations are fulfilled in this regard. Within the scope of audit activities, preventive and deterrent audits are carried out, helping to strengthen internal control awareness and measures.

4.2. Activity of the Board of Directors
Date of the last board evaluation conducted	None.
Whether the board evaluation was externally facilitated	Hayır (No)
Whether all board members released from their duties at the GSM	Evet (Yes)
Name(s) of the board member(s) with specific delegated duties and authorities, and descriptions of such duties	There is no delegation of authority among the members of the Board of Directors.
Number of reports presented by internal auditors to the audit committee or any relevant committee to the board	None.
Specify the name of the section or page number of the annual report that provides the summary of the review of the effectiveness of internal controls	In the 2025 Annual Report of the Board of Directors, it is included in the article 3.4 Risk Management and Internal Control Mechanism under the Corporate Governance heading.
Name of the Chairman	Atilla Sevinçli
Name of the CEO	Atilla Sevinçli
If the CEO and Chair functions are combined: provide the link to the relevant PDP annoucement providing the rationale for such combined roles	https://www.kap.org.tr/tr/Bildirim/985474
Link to the PDP notification stating that any damage that may be caused by the members of the board of directors during the discharge of their duties is insured for an amount exceeding 25% of the company's capital	https://www.kap.org.tr/en/Bildirim/1527504
The name of the section on the corporate website that demonstrates current diversity policy targeting women directors	None.
The number and ratio of female directors within the Board of Directors	There are no female members on the Board of Directors.

Board Members

Name-Surname	Real Person Acting on Behalf of Legal Person Member	Gender	Title	Profession	The First Election Date To Board	Whether Executive Director or Not	Positions Held in the Company in the Last 5 Years	Current Positions Held Outside the Company	Whether the Director has at Least 5 Years’ Experience on Audit, Accounting and/or Finance or not	Share in Capital (%)	The Share Group that the Board Member Representing	Independent Board Member or not	Link To PDP Notification That Includes The Independency Declaration	Whether the Independent Director Considered By The Nomination Committee	Whether She/He is the Director Who Ceased to Satisfy The Independence or Not	Committees Charged and Task
ATİLLA SEVİNÇLİ					12/04/2021		Chairman of the Board	S&Mohr İplik Fabrikaları A.Ş. Yönetim Kurulu Başkanı, Sevinçli Yatırım Holding A.Ş. Yönetim Kurulu Başkanı, Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş. Yönetim Kurulu Başkanı, Altera Medikal Sanayi ve Ticaret A.Ş. Yönetim Kurulu Başkanı, Vits Gıda Ürün Geliştirme Laboratuvarları Sanayi ve Ticaret A.Ş. Yönetim Kurulu Başkanı, Latill Medikal ve Kişisel Bakım Ürünleri Sanayi A.Ş. Yönetim Kurulu Başkanı, Altera Mağazacılık Satış ve Pazarlama İşletmeleri A.Ş. Yönetim Kurulu Başkanı		56.38	A and B
MERT SEVİNÇLİ		Male	Deputy Chairman of the Board	Businessman / Businesswoman	12/04/2021	Executive	Deputy Chairman of the Board	S&Mohr İplik Fabrikaları A.Ş. Yönetim Kurulu Üyesi,Sevinçli Yatırım Holding A.Ş. Yönetim Kurulu Başkan Vekili, Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş. Yönetim Kurulu Üyesi, Meditera Medical LTD Direktörü, Altera Medikal Sanayi ve Ticaret A.Ş. Yönetim Kurulu Başkan Vekili, Latill Medikal ve Kişisel Bakım Ürünleri Sanayi A.Ş. Yönetim Kurulu Başkan Vekili, Altera Mağazacılık Satış ve Pazarlama İşletmeleri A.Ş. Yönetim Kurulu Üyesi	Yes	23.03	A and B	Dependent Member				Member of the Sustainability Committee
ADNAN YILDIRIM		Male	Member of the Board	Sworn-in Certified Public Accountant	12/04/2021	Non-Executive	Member of the Board	Batı Yeminli Mali Müşavirlik ve Bağımsız Denetim A.Ş. Yönetim Kurulu Başkanı, Pamukkale Danışmanlık A.Ş. Yönetim Kurulu Başkanı, Mistral Gayrimenkul Yatırım Ortaklığı A.Ş. Bağımsız Yönetim Kurulu Üyesi, Vestel Elektronik Sanayi ve Ticaret A.Ş. Bağımsız Yönetim Kurulu Başkan Vekili, Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş. Bağımsız Yönetim Kurulu Üyesi, Alkim Kağıt Sanayi ve Ticaret A.Ş. Bağımsız Yönetim Kurulu Üyesi	Yes	-	-	Independent Member	https://www.kap.org.tr/tr/Bildirim/1006558	Considered	No	Chairman of the Audit Committee, Chairman of the Early Detection of Risk Committee, Member of the Corporate Governance Committee
ETEM ALNIGENİŞ		Male	Member of the Board	Medical Doctor	12/04/2021	Non-Executive	Member of the Board	-	Yes	-	-	Independent Member	https://www.kap.org.tr/tr/Bildirim/1006558	Considered	No	Chairman of the Corporate Governance Committee, Member of the Audit Committee, Member of the Early Detection of Risk Committee
LEVENT METE ÖZGÜRBÜZ		Male	Member of the Board	Businessman / Businesswoman	03/03/2022	Non-Executive	Member of the Board	President of the TOBB Türkiye Medikal Meclisi, Managing Partner of Burgeon Biyoteknoloji ve San. Tic. A.Ş., Managing Partner of BMT Baps Biyo Malzeme San. Tic. A.Ş.	Yes	-	-	Dependent Member	-	Not Considered	No

4.4. Meeting Procedures of the Board of Directors
Number of physical or electronic board meetings in the reporting period	The number of physical meetings held in 2025 was 31.
Director average attendance rate at board meetings	%87
Whether the board uses an electronic portal to support its work or not	Hayır (No)
Number of minimum days ahead of the board meeting to provide information to directors, as per the board charter	Although there is no written rule, in practice, information and documents related to the issues on the agenda of the Board of Directors meeting are made available to the members of the Board of Directors for review sufficiently in advance of the meeting in order to ensure equal flow of information.
The name of the section on the corporate website that demonstrates information about the board charter	Investor Relations / Articles of Association
Number of maximum external commitments for board members as per the policy covering the number of external duties held by directors	None.

4.5. Board Committees
Page numbers or section names of the annual report where information about the board committees are presented	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.
Link(s) to the PDP announcement(s) with the board committee charters	https://www.kap.org.tr/tr/Bildirim/979837 - https://www.kap.org.tr/en/Bildirim/1477962

Composition of Board Committees-I

Names Of The Board Committees	Name Of Committees Defined As "Other" In The First Column	Name-Surname of Committee Members	Whether Committee Chair Or Not	Whether Board Member Or Not
Denetim Komitesi (Audit Committee)	-	Adnan YILDIRIM	Evet (Yes)	Yönetim kurulu üyesi (Board member)
Denetim Komitesi (Audit Committee)	-	Etem ALNIGENİŞ	Hayır (No)	Yönetim kurulu üyesi (Board member)
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)	-	Adnan YILDIRIM	Evet (Yes)	Yönetim kurulu üyesi (Board member)
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)	-	Etem ALNIGENİŞ	Hayır (No)	Yönetim kurulu üyesi (Board member)
Kurumsal Yönetim Komitesi (Corporate Governance Committee)	-	Etem ALNIGENİŞ	Evet (Yes)	Yönetim kurulu üyesi (Board member)
Kurumsal Yönetim Komitesi (Corporate Governance Committee)	-	Adnan YILDIRIM	Hayır (No)	Yönetim kurulu üyesi (Board member)
Kurumsal Yönetim Komitesi (Corporate Governance Committee)	-	Hüseyin SAYGAN	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Ayşem Ferda SEVİNÇLİ	Evet (Yes)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Mert SEVİNÇLİ	Hayır (No)	Yönetim kurulu üyesi (Board member)
Diğer (Other)	Sustainability Committee	Hicret YANIK	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Cenk Kılıç KALKAN	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Vuslat ÇAVUŞ	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Ozan AKDAĞ	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)
Diğer (Other)	Sustainability Committee	Yusuf PEKGÜZEL	Hayır (No)	Yönetim kurulu üyesi değil (Not board member)

4.5. Board Committees-II
Specify where the activities of the audit committee are presented in your annual report or website (Page number or section name in the annual report/website)	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.
Specify where the activities of the corporate governance committee are presented in your annual report or website (Page number or section name in the annual report/website)	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.
Specify where the activities of the nomination committee are presented in your annual report or website (Page number or section name in the annual report/website)	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.
Specify where the activities of the early detection of risk committee are presented in your annual report or website (Page number or section name in the annual report/website)	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.
Specify where the activities of the remuneration committee are presented in your annual report or website (Page number or section name in the annual report/website)	In the 2025 Annual Report of the Board of Directors, under the heading of Corporate Governance, the Number, Structure and Independence of the Committees Established within the Board of Directors is included in the article.

4.6. Financial Rights
Specify where the operational and financial targets and their achievement are presented in your annual report (Page number or section name in the annual report)	2025 is included in the Annual Report of the Board of Directors under the heading Financial Status.
Specify the section of website where remuneration policy for executive and non-executive directors are presented.	Investor Relations>Policies>Board of Directors and Senior Management Remuneration Policy
Specify where the individual remuneration for board members and senior executives are presented in your annual report (Page number or section name in the annual report)	2025 is included in the Board of Directors Annual Report under the heading of Senior Management.

Composition of Board Committees-II

Names Of The Board Committees	Name Of Committees Defined As "Other" In The First Column	The Percentage Of Non-executive Directors	The Percentage Of Independent Directors In The Committee	The Number Of Meetings Held In Person	The Number Of Reports On Its Activities Submitted To The Board
Denetim Komitesi (Audit Committee)	-	100%	100%	7 meetings were held in 2024.	4 reports were submitted in 2025.
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)	-	100%	100%	6 meetings were held in 2025.	In 2025, they did not submit any report.
Kurumsal Yönetim Komitesi (Corporate Governance Committee)	-	100%	67%	6 meetings were held in 2025.	3 reports were submitted in 2025.
Diğer (Other)	Sustainability Committee	0%	0%	2 meetings were held in 2025.	1 reports were submitted in 2025.